Zhuo, W., Zhang, L., Zhu, Y., Xie, Q., Zhu, B., & Chen, Z. (2015). Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: A Connectivity Mapping analysis and an experimental study. Am J Cancer Res.
Citação norma ChicagoZhuo, Wenlei, Liang Zhang, Yi Zhu, Qichao Xie, Bo Zhu, and Zhengtang Chen. "Valproic Acid, an Inhibitor of Class I Histone Deacetylases, Reverses Acquired Erlotinib-resistance of Lung Adenocarcinoma Cells: A Connectivity Mapping Analysis and an Experimental Study." Am J Cancer Res 2015.
Citação norma MLAZhuo, Wenlei, et al. "Valproic Acid, an Inhibitor of Class I Histone Deacetylases, Reverses Acquired Erlotinib-resistance of Lung Adenocarcinoma Cells: A Connectivity Mapping Analysis and an Experimental Study." Am J Cancer Res 2015.